Invest Now
Products +
Pricing
Trading & Investing +
Calculators +
Support +
Learn +
IPO +
Partner
About us +
#AndekhaSach New
Login Open an account
Samco securities limited
Samco Star Rating Ads

Marksans Pharma Ltd Share Price

₹ 320.05 -5.85 (-1.80%)

Updated on 18-12-2024 4:38 PM

Stock Rating

Pros 3

 

Cons 5

Marksans Pharma Ltd Price Performance

  • Day's Low
  • ₹318.6
  • Day's High
  • ₹332.4
₹ 320.05
  • 52-w low
  • ₹130
  • 52-w high
  • ₹358.7
320.05
  • Day's open
    ₹327.9
  • Previous close
    ₹325.899994
  • VWAP
    ₹325.84
  • Lower price band
    ₹260.75
  • Upper price band
    ₹391.05

Today's Market Action

The last traded share price of Marksans Pharma Ltd was 320.05 down by -1.80% on the NSE. Its last traded stock price on BSE was 320.05 down by -1.63%. The total volume of shares on NSE and BSE combined was 2,277,607 shares. Its total combined turnover was Rs 74.22 crores.

Marksans Pharma Ltd Medium and Long Term Market Action

Marksans Pharma Ltd hit a 52-week high of 358.7 on 02-12-2024 and a 52-week low of 130 on 04-06-2024. The stock price of Marksans Pharma Ltd is up by 4% over the last one month. It is up by 98.54% over the last one year. Don't forget to check the full stock price history in the table below.

Marksans Pharma Ltd Fundamentals

  • Market Cap (Cr): 13971

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Marksans Pharma Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Marksans Pharma Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Marksans Pharma Ltd

Data not available.

Marksans Pharma Ltd FAQ's

What is Share Price of Marksans Pharma Ltd?

What is the Market Cap of Marksans Pharma Ltd?

What is PE Ratio of Marksans Pharma Ltd?

What is PB Ratio of Marksans Pharma Ltd?

What is the CAGR of Marksans Pharma Ltd?

How to Buy Marksans Pharma Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.09. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 72.07 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 228 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Yellow line
85
100.00%
100.00% People are bullish about Marksans Pharma Ltd
0.00%
0.00 % People are bearish about Marksans Pharma Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Marksans Pharma Ltd

₹ 320.05 -5.85 (-1.80%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91